pT1 clear cell renal cell carcinoma

The majority of patients with pT1 clear cell renal cell carcinoma (RCC) are cured with nephrectomy. However, a few patients will die of RCC. In several studies, MIB‐1 proliferative activity was identified as an independent predictor of survival in patients with RCC. The objective of the current study was to examine MIB‐1 proliferative activity in a large series of patients with pT1 clear cell RCC who were treated uniformly with radical nephrectomy, and to examine the association between proliferative activity and cancer specific survival in a multivariate model incorporating tumor size, nuclear grade, and tumor necrosis.

[1]  J. Cheville,et al.  Stage pT1 conventional (clear cell) renal cell carcinmoa: pathological features associated with cancer specific survival. , 2001, The Journal of urology.

[2]  B. Delahunt,et al.  Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. , 2001, Human pathology.

[3]  A. Renshaw,et al.  Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. , 1997, The American journal of surgical pathology.

[4]  R. Fietkau,et al.  Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas. , 1997, Anticancer research.

[5]  M. Marberger,et al.  Proliferating cell nuclear antigen and MIB-1. An alternative to classic prognostic indicators in renal cell carcinomas? , 1997, American journal of clinical pathology.

[6]  W. Jochum,et al.  Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas: A clinicopathologic study of 58 patients using mitotic count, MIB‐1 staining, and DNA cytophotometry , 1996, Cancer.

[7]  J. Gerdes,et al.  The proliferation‐associated Ki‐67 protein: definition in molecular terms , 1994, Cell proliferation.

[8]  H. Kirchner,et al.  Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  R. L. Prentice,et al.  A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .